Related Experiment Video
Updated: Feb 8, 2026

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
Published on: October 19, 2015
GMP-compliant batch manufacturing of dextran-coated iron oxide nanoparticles: A process development case study.
Helmut Spielvogel1, Eveline Schreiber1, Teresa Siegert1
1ENT-Department, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-endowed Professorship for Nanomedicine, Universitätsklinikum Erlangen, Erlangen, Germany.
Superparamagnetic iron oxide nanoparticles (SPIONs) like SEONDex30 offer advanced MRI contrast imaging. Manufacturing these investigational medicinal products requires strict Good Manufacturing Practice (GMP) guidelines for clinical trials.
Area of Science:
- Nanomedicine and Materials Science
- Biotechnology and Pharmaceutical Manufacturing
Background:
- Superparamagnetic iron oxide nanoparticles (SPIONs) are valuable for magnetic accumulation and MRI visualization.
- SEONDex30, developed by SEON, features an iron oxide core with a dextran coating, designed for enhanced liver imaging in clinical trials.
- Current iron oxide nanoparticle contrast agents face limitations in application safety, long-term tolerance, and imaging quality.
Purpose of the Study:
- To detail the Good Manufacturing Practice (GMP)-compliant development and manufacturing process for SEONDex30 SPIONs.
- To establish SEONDex30 as an Investigational Medicinal Product (IMP) for human clinical trials.
- To demonstrate the potential superiority of SEONDex30 over existing MRI contrast agents for liver imaging.
Main Methods:
- Fabrication of SEONDex30 nanoparticles with an iron oxide core (magnetite/maghemite) and a cross-linked dextran shell.
- Adherence to Good Manufacturing Practice (GMP) guidelines for nanomedicine production, including quality control and regulatory compliance.
- Exploration of alternative biocompatible coating materials (proteins, lipids, polymers) and functionalization with active pharmaceutical ingredients (APIs).
Main Results:
- The report illustrates a process-oriented technical case study of GMP-compliant nanoparticle manufacturing.
- Requirements for starting materials, technology, production processes, and quality inspections for SEONDex30 are outlined.
- The described manufacturing standards are representative for future iron oxide-based nanoparticle medicinal products.
Conclusions:
- GMP-compliant manufacturing is essential for the clinical translation of nanomedicines like SEONDex30.
- Specialized pharmaceutical companies can provide necessary resources for institutions lacking in-house production capabilities.
- Further applications for functionalized SPIONs include targeted cancer therapies and controlled drug delivery.
More Related Videos
09:36Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
08:59Fabrication of a Functionalized Magnetic Bacterial Nanocellulose with Iron Oxide Nanoparticles
Published on: May 26, 2016
Related Concept Videos
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Oxidation Numbers
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
Steel Manufacturing
During this smelting process, limestone plays a crucial role by forming slag. Slag captures impurities within the molten iron, such...
Oxidation-Reduction Reactions
Pinching-off of Coated Vesicles